Asthma: NIH Clinical Trial Finds Relief for Seasonal Asthma Attacks in Youth

NIH Clinical Trial Finds Relief for Seasonal Asthma Attacks in Youth

An NIH-sponsored clinical trial found that the addition of the drug omalizumab to NIH guidelines-based therapy for asthma nearly eliminated seasonal increases in asthma attacks and decreased asthma symptoms among young people.

Did you know?

In the United States, asthma affects approximately 18 million adults and 7 million children under the age of 18.

The number of asthma attacks rises in the spring when more allergens are in the air and in the fall when the occurrence of respiratory viruses increases.


Read more about the clinical trial [NIH Study Finds Omalizumab Relieves Seasonal Asthma Attacks in Youth] and NIAID’s role in addressing asthma.
Asthma